Related Experiment Video

Updated: Jun 18, 2026

Ubiquitin Chain Analysis by Parallel Reaction Monitoring
08:33

Ubiquitin Chain Analysis by Parallel Reaction Monitoring

Published on: June 17, 2020

Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference

Jeffrey G Marblestone1

  • 1Progenra Inc, 271A Great Valley Parkway, Malvern, PA 19355, USA. marblestone@progenra.com

Idrugs : the Investigational Drugs Journal
|November 28, 2009
PubMed

Insights

This conference report covers novel ubiquitin drug research, focusing on new oncology targets and proteasome inhibitor therapies for multiple myeloma. Emerging ubiquitin-based therapeutics and their clinical applications were highlighted.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology and Therapeutics
  • Oncology

Background:

  • The Ubiquitin Drug Discovery & Diagnostics conference convened to discuss advancements in ubiquitin research.
  • Ubiquitin pathways are increasingly recognized as critical in disease pathogenesis, particularly cancer.

Purpose of the Study:

  • To summarize key findings and emerging trends from the Ubiquitin Drug Discovery & Diagnostics conference.
  • To highlight novel therapeutic strategies targeting ubiquitin pathways in oncology and multiple myeloma.

Main Methods:

  • Review of selected presentations from the conference.
  • Focus on investigational drugs and their mechanisms of action.

Main Results:

  • Discussion of emerging ubiquitin targets in various cancers.
  • Overview of proteasome inhibitor therapy advancements for multiple myeloma.
  • Mention of specific investigational drugs including MLN-4924, MLN-9708, P-005091, CEP-18770, and carfilzomib.

Conclusions:

  • The field of ubiquitin drug discovery is rapidly advancing with promising therapeutic candidates.
  • Targeting ubiquitin pathways offers significant potential for treating challenging diseases like multiple myeloma and other cancers.

More Related Videos

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

Detection of Protein Ubiquitination09:00

Detection of Protein Ubiquitination

Published on: August 19, 2009

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.